Bio-Techne Corp (FRA:TE1)
€ 76.5 1 (1.32%) Market Cap: 11.96 Bil Enterprise Value: 12.28 Bil PE Ratio: 66.51 PB Ratio: 6.55 GF Score: 92/100

Bio-Techne Corp at Jefferies Healthcare Conference (Virtual) Transcript

Jun 03, 2021 / 05:00PM GMT
Release Date Price: €82.5
Charles R. Kummeth
Bio-Techne Corporation - CEO, President & Director

Well, hi. Welcome to the Bio-Techne presentation. I'm Chuck Kummeth, CEO of Bio-Techne. And I'll be taking through -- you through a few slides. Many of you may have seen me before. We've updated a lot of deck, and we have, hopefully, what you think is a lot more new and more useful information.

Next slide. Of course, we have to start with our safe harbor, and you guys know what these are and how they read. And of course, we all want you to get on our website and check out all our reconciliation statements and see where we get all our numbers from.

Next slide. So our high level slide, talking about the company. We've grown a lot, especially in the last couple of years. We're up now around 2,600 employees after the Asuragen acquisition, and we are at 35 locations. We are coming on the end of our fiscal year here, but going off of last year's numbers, officially $739 million, we're going to blow that number out of the water this year, as you all know.

We have won wonderful stocks in what we think, and we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot